Eric Wieder
Overview
Explore the profile of Eric Wieder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
He H, Courtney A, Wieder E, Sastry K
J Vis Exp
. 2010 Apr;
(38).
PMID: 20414189
The rhesus macaque model is currently the best available model for HIV-AIDS with respect to understanding the pathogenesis as well as for the development of vaccines and therapeutics(1,2,3). Here, we...
12.
Guerrouahen B, Futami M, Vaklavas C, Kanerva J, Whichard Z, Nwawka K, et al.
Clin Cancer Res
. 2010 Feb;
16(4):1149-58.
PMID: 20145167
Purpose: Dasatinib is a dual Src/Abl inhibitor recently approved for Bcr-Abl+ leukemias with resistance or intolerance to prior therapy. Because Src kinases contribute to multiple blood cell functions by triggering...
13.
Guerrouahen B, Wieder E, Blanchard E, Lee F, Aplenc R, Corey S
Pediatr Blood Cancer
. 2009 Jun;
53(6):1132-5.
PMID: 19484755
Tyrosine kinase inhibitors, such as imatinib, have dramatically improved the outcomes for patients with selected cancers. For imatinib, western blotting of phospho-CrkL was an insensitive, indirect, and descriptive method to...
14.
Lu S, Wieder E, Komanduri K, Ma Q, Molldrem J
Adv Pharmacol
. 2004 Oct;
51:255-70.
PMID: 15464913
No abstract available.
15.
Napolitano L, Stoddart C, Hanley M, Wieder E, McCune J
J Immunol
. 2003 Jul;
171(2):645-54.
PMID: 12847229
IL-7 is a critical component of thymopoiesis in animals and has recently been shown to play an important role in T cell homeostasis. Although there is increasing interest in the...
16.
Molldrem J, Lee P, Kant S, Wieder E, Jiang W, Lu S, et al.
J Clin Invest
. 2003 Mar;
111(5):639-47.
PMID: 12618518
We have shown that cytotoxic T lymphocytes specific for PR1, an HLA-A2-restricted nonopeptide derived from proteinase 3, kill leukemia cells and may contribute to the elimination of chronic myelogenous leukemia...
17.
Molldrem J, Komanduri K, Wieder E
Curr Opin Hematol
. 2002 Oct;
9(6):503-8.
PMID: 12394172
The graft-versus-leukemia (GVL) effect associated with allogeneic blood and marrow transplantation has largely been a clinically described phenomenon until recently. We are beginning to understand the cellular and molecular nature...